CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $547,000 | -31.3% | 459,299 | +4.0% | 0.00% | – |
| Q2 2022 | $796,000 | -18.2% | 441,725 | -8.2% | 0.00% | – |
| Q1 2022 | $973,000 | -28.0% | 481,305 | -3.5% | 0.00% | – |
| Q4 2021 | $1,352,000 | -22.3% | 498,807 | +28.0% | 0.00% | – |
| Q3 2021 | $1,739,000 | -11.1% | 389,731 | +15.5% | 0.00% | -100.0% |
| Q2 2021 | $1,957,000 | +22.5% | 337,494 | +48.3% | 0.00% | – |
| Q1 2021 | $1,598,000 | +45.4% | 227,645 | -0.6% | 0.00% | – |
| Q4 2020 | $1,099,000 | -27.6% | 229,040 | -12.1% | 0.00% | -100.0% |
| Q3 2020 | $1,519,000 | -0.1% | 260,641 | +15.8% | 0.00% | 0.0% |
| Q2 2020 | $1,520,000 | +1570.3% | 225,170 | +1467.7% | 0.00% | – |
| Q1 2020 | $91,000 | -70.0% | 14,363 | -50.6% | 0.00% | – |
| Q4 2019 | $303,000 | +82.5% | 29,078 | -31.2% | 0.00% | – |
| Q3 2019 | $166,000 | -71.3% | 42,258 | +8.6% | 0.00% | – |
| Q2 2019 | $578,000 | -36.1% | 38,906 | +6.8% | 0.00% | – |
| Q1 2019 | $905,000 | +87.0% | 36,418 | +35.4% | 0.00% | – |
| Q4 2018 | $484,000 | +55.1% | 26,896 | +153.2% | 0.00% | – |
| Q3 2018 | $312,000 | -94.6% | 10,623 | -91.6% | 0.00% | -100.0% |
| Q2 2018 | $5,765,000 | -40.8% | 126,763 | -31.3% | 0.00% | -25.0% |
| Q1 2018 | $9,743,000 | +81.5% | 184,528 | +133.7% | 0.00% | +100.0% |
| Q4 2017 | $5,368,000 | -21.1% | 78,944 | -4.3% | 0.00% | -33.3% |
| Q3 2017 | $6,800,000 | +21.7% | 82,512 | +38.2% | 0.00% | 0.0% |
| Q2 2017 | $5,588,000 | +6250.0% | 59,694 | +4191.4% | 0.00% | – |
| Q1 2017 | $88,000 | +66.0% | 1,391 | +14.1% | 0.00% | – |
| Q4 2016 | $53,000 | -99.4% | 1,219 | -99.5% | 0.00% | -100.0% |
| Q3 2016 | $8,181,000 | +3172.4% | 226,933 | +1146.1% | 0.01% | – |
| Q2 2016 | $250,000 | +1370.6% | 18,212 | +2075.9% | 0.00% | – |
| Q1 2016 | $17,000 | -99.5% | 837 | -99.2% | 0.00% | -100.0% |
| Q4 2015 | $3,533,000 | +182.4% | 100,907 | +641.6% | 0.00% | +100.0% |
| Q3 2015 | $1,251,000 | +76.7% | 13,607 | +69.0% | 0.00% | – |
| Q2 2015 | $708,000 | -40.0% | 8,050 | -49.4% | 0.00% | -100.0% |
| Q1 2015 | $1,180,000 | +146.9% | 15,900 | +86.2% | 0.00% | – |
| Q4 2014 | $478,000 | -35.8% | 8,537 | -47.9% | 0.00% | -100.0% |
| Q3 2014 | $744,000 | +127.5% | 16,400 | +107.6% | 0.00% | – |
| Q2 2014 | $327,000 | -58.6% | 7,900 | -30.7% | 0.00% | -100.0% |
| Q1 2014 | $790,000 | +25.4% | 11,400 | +9.1% | 0.00% | – |
| Q4 2013 | $630,000 | +1700.0% | 10,450 | +1720.6% | 0.00% | – |
| Q3 2013 | $35,000 | – | 574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |